About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Diabetes Clinical Trials in Tennessee | 21 Studies

Clinical Trials DiabetesTennessee

Diabetes Clinical Trials in Tennessee

Find 21 clinical trials for diabetes near Tennessee. Connect with research centers in your area.

All Diabetes trials nationwide All trials in Tennessee

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 21 trials

CompletedPharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes MellitusThe purpose of this study is to determine the pharmacokinetic and safety profile of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus.NCT00957268·Miami, Florida and 6 others CompletedAffects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic GastroparesisThe purpose of this study is to test the safety and effectiveness of two dosage levels (10mg and 20mg) of TZP-102 compared to placebo (capsule that looks like the study drug but…NCT01452815·Huntsville, Alabama and 51 others

Diabetes Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedAn Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesThis is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace.NCT00229658·Birmingham, Alabama and 106 others

CompletedEfficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesThe purpose of this study is to evaluate the safety and effectiveness of alogliptin combined with metformin, once daily (QD) or twice daily (BID), in participants with Type 2…NCT01023581·Dothan, Alabama and 200 others

CompletedAfrezza® INHALE-1 Study in PediatricsINHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the Afrezza group) versus…NCT04974528·Los Angeles, California and 38 others

Active not recruitingEversense® Non-adjunctive Use Post Approval StudyThis is a non-blinded, prospective, multi-center, single arm longitudinal cohort study (patient serving as their own control), to evaluate the effectiveness of diabetes with the…NCT04836546·Los Angeles, California and 22 others

Active not recruitingGATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesThe purpose of this study is to check that a new insulin pump, called NMX8, is safe when used with a continuous glucose monitoring sensor called Disposable Sensor 5/Simplera Sync…NCT07228117·Little Rock, Arkansas and 32 others

CompletedPost Approval Study of the Eversense® Continuous Glucose MonitoringA Post Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System over repeat insertion and removal cycles and…NCT03908125·Newport Beach, California and 16 others

CompletedStudy of a High-Dose Aflibercept in Participants With Diabetic Eye DiseaseThe primary objective of the study is to determine if treatment with high-dose aflibercept (HD) at intervals of 12 or 16 weeks provides non-inferior best corrected visual acuity…NCT04429503·Phoenix, Arizona and 137 others

CompletedClinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusThis open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing…NCT00108004·Anaheim, California and 47 others

CompletedA 2-Month Safety Follow-Up TrialThe main purpose of the trial is to evaluate pulmonary function in subjects who had completed any one of the 4 MKC parent trials (MKC-TI-009, MKC-TI-102, MKC-TI-103, or…NCT00741429·Birmingham, Alabama and 149 others

CompletedEfficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in DiabeticsThis trial is conducted in the United States of America (USA).NCT00773279·Burlingame, California and 64 others

CompletedComparison of Glycemic Control in Obese Diabetics Using Three Different Pen NeedlesAnxiety about needles is a concern commonly expressed by diabetics when beginning insulin therapy.NCT01231984·Escondido, California and 9 others

WithdrawnSYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 DiabetesThe purpose of this study is to find out how well a new continuous glucose monitor works for people with diabetes.NCT06719531·Birmingham, Alabama and 27 others

RecruitingContinuous Glucose Monitoring for Outpatient Diabetes Management After Hospital DischargeThis study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding…NCT06852950·Nashville, Tennessee

CompletedClinical Evaluation of BD NEXT Pen NeedleThis prospective, multi-center, 2 period cross-over study is designed to determine if people who use injection pens for subcutaneous medication delivery prefer the BD NEXT pen…NCT01852136·Toms River, New Jersey and 4 others

CompletedComparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin GlarginePrimary Objective: To demonstrate non-inferiority of SAR341402 versus NovoLog/NovoRapid in glycated hemoglobin A1c (HbA1c) change from baseline to Week 26 in participants with…NCT03211858·Little Rock, Arkansas and 81 others

CompletedPhase 2 Study of INV-202 in Patients With Diabetic Kidney DiseaseThe study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the treatment of adult participants…NCT05514548·Garden Grove, California and 71 others

CompletedEvaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and PediatricsThe purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days).NCT04436822·Escondido, California and 17 others

RecruitingCardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 DiabetesThis study aims to understand the heart and blood sugar health benefits of using an adjunctive therapy to lower high insulin levels in people with type 1 diabetes.NCT06609356·Nashville, Tennessee

Page 1 of 2Next

Other Conditions in Tennessee

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia